MBX: the cash flow

MyFinsight

For the year ending 2025-12-31, MBX had $25,938K increase in cash & cash equivalents over the period. -$81,878K in free cash flow.

Cash Flow	2025-12-31
Net loss	-86,971
Stock-based compensation expense	8,677
Non cash operating lease expense	133
Accretion and amortization of marketable securities, net	3,611
Depreciation expense	248
Prepaid expenses and other current assets	2,697
Accounts payable	-2,456
Accrued expenses	6,796
Other assets	-8
Operating lease right-of-use asset	501
Operating lease liability	425
Net cash used in operating activities	-79,949
Purchases of property and equipment	1,929
Purchases of marketable securities	358,148
Maturities of marketable securities	267,872
Call redemptions of marketable securities	8,500
Net cash used in investing activities	-83,705
Proceeds from public offering, net of underwriting discounts and commissions	187,948
Proceeds from initial public offering, net of underwriting discounts and commissions	0
Proceeds from exercise of common stock options	2,415
Payments related to offering costs	771
Proceeds from the issuance of series c convertible preferred stock	0
Preferred stock issuance costs	0
Net cash provided by financing activities	189,592
Net increase in cash and cash equivalents	25,938
Cash and cash equivalents, beginning of period	49,351
Cash and cash equivalents, end of period	75,289

Unit: Thousand (K) dollars (except for numbers of shares and EPS).